148 related articles for article (PubMed ID: 38103783)
21. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
[TBL] [Abstract][Full Text] [Related]
22. Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.
Carnathan D; Lawson B; Yu J; Patel K; Billingsley JM; Tharp GK; Delmas OM; Dawoud R; Wilkinson P; Nicolette C; Cameron MJ; Sekaly RP; Bosinger SE; Silvestri G; Vanderford TH
J Virol; 2018 May; 92(9):. PubMed ID: 29467313
[TBL] [Abstract][Full Text] [Related]
23. Changes to the Simian Immunodeficiency Virus (SIV) Reservoir and Enhanced SIV-Specific Responses in a Rhesus Macaque Model of Functional Cure after Serial Rounds of Romidepsin Administrations.
Kleinman AJ; Sivanandham S; Sette P; Sivanandham R; Policicchio BB; Xu C; Penn E; Brocca-Cofano E; Le Hingrat Q; Ma D; Pandrea I; Apetrei C
J Virol; 2022 Jun; 96(12):e0044522. PubMed ID: 35638831
[TBL] [Abstract][Full Text] [Related]
24. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).
Luciw PA; Pratt-Lowe E; Shaw KE; Levy JA; Cheng-Mayer C
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7490-4. PubMed ID: 7638218
[TBL] [Abstract][Full Text] [Related]
25. Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.
Kilgore KM; Murphy MK; Burton SL; Wetzel KS; Smith SA; Xiao P; Reddy S; Francella N; Sodora DL; Silvestri G; Cole KS; Villinger F; Robinson JE; Pulendran B; Hunter E; Collman RG; Amara RR; Derdeyn CA
J Virol; 2015 Aug; 89(16):8130-51. PubMed ID: 26018167
[TBL] [Abstract][Full Text] [Related]
26. Simian Immunodeficiency Virus SIVmac239, but Not SIVmac316, Binds and Utilizes Human CD4 More Efficiently than Rhesus CD4.
Fellinger CH; Gardner MR; Bailey CC; Farzan M
J Virol; 2017 Sep; 91(18):. PubMed ID: 28679752
[TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin VH gene diversity and somatic hypermutation during SIV infection of rhesus macaques.
Guo K; Halemano K; Schmitt K; Katuwal M; Wang Y; Harper MS; Heilman KJ; Kuwata T; Stephens EB; Santiago ML
Immunogenetics; 2015 Jul; 67(7):355-70. PubMed ID: 25994147
[TBL] [Abstract][Full Text] [Related]
28. Isolation of monoclonal antibodies with predetermined conformational epitope specificity.
Sholukh AM; Mukhtar MM; Humbert M; Essono SS; Watkins JD; Vyas HK; Shanmuganathan V; Hemashettar G; Kahn M; Hu SL; Montefiori DC; Polonis VR; Schur PH; Ruprecht RM
PLoS One; 2012; 7(6):e38943. PubMed ID: 22737224
[TBL] [Abstract][Full Text] [Related]
29. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.
McChesney MB; Collins JR; Lu D; Lu X; Torten J; Ashley RL; Cloyd MW; Miller CJ
J Virol; 1998 Dec; 72(12):10029-35. PubMed ID: 9811741
[TBL] [Abstract][Full Text] [Related]
30. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
Cole KS; Alvarez M; Elliott DH; Lam H; Martin E; Chau T; Micken K; Rowles JL; Clements JE; Murphey-Corb M; Montelaro RC; Robinson JE
Virology; 2001 Nov; 290(1):59-73. PubMed ID: 11883006
[TBL] [Abstract][Full Text] [Related]
31. Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells.
Sundling C; Phad G; Douagi I; Navis M; Karlsson Hedestam GB
J Immunol Methods; 2012 Dec; 386(1-2):85-93. PubMed ID: 22989932
[TBL] [Abstract][Full Text] [Related]
32. Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.
Palesch D; Bosinger SE; Mavigner M; Billingsley JM; Mattingly C; Carnathan DG; Paiardini M; Chahroudi A; Vanderford TH; Silvestri G
J Virol; 2018 Jul; 92(14):. PubMed ID: 29720521
[TBL] [Abstract][Full Text] [Related]
33. Two Human Monoclonal HLA-Reactive Antibodies Cross-React with Mamu-B*008, a Rhesus Macaque MHC Allotype Associated with Control of Simian Immunodeficiency Virus Replication.
de Groot NG; Heijmans CMC; Bezstarosti S; Bruijnesteijn J; Haasnoot GW; Mulder A; Claas FHJ; Heidt S; Bontrop RE
J Immunol; 2021 Apr; 206(8):1957-1965. PubMed ID: 33692147
[TBL] [Abstract][Full Text] [Related]
34. Induction of B cell hyperplasia in simian immunodeficiency virus-infected rhesus macaques with the simian homologue of Kaposi's sarcoma-associated herpesvirus.
Wong SW; Bergquam EP; Swanson RM; Lee FW; Shiigi SM; Avery NA; Fanton JW; Axthelm MK
J Exp Med; 1999 Sep; 190(6):827-40. PubMed ID: 10499921
[TBL] [Abstract][Full Text] [Related]
35. Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif.
Breed MW; Elser SE; Torben W; Jordan AP; Aye PP; Midkiff C; Schiro F; Sugimoto C; Alvarez-Hernandez X; Blair RV; Somasunderam A; Utay NS; Kuroda MJ; Pahar B; Wiseman RW; O'Connor DH; LaBranche CC; Montefiori DC; Marsh M; Li Y; Piatak M; Lifson JD; Keele BF; Fultz PN; Lackner AA; Hoxie JA
J Virol; 2015 Oct; 89(20):10156-75. PubMed ID: 26223646
[TBL] [Abstract][Full Text] [Related]
36. Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression.
Dykhuizen M; Mitchen JL; Montefiori DC; Thomson J; Acker L; Lardy H; Pauza CD
J Gen Virol; 1998 Oct; 79 ( Pt 10)():2461-7. PubMed ID: 9780052
[TBL] [Abstract][Full Text] [Related]
37. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
38. Infectivity of titered doses of simian immunodeficiency virus clone E11S inoculated intravenously into rhesus macaques (Macaca mulatta).
Benveniste RE; Roodman ST; Hill RW; Knott WB; Ribas JL; Lewis MG; Eddy GA
J Med Primatol; 1994; 23(2-3):83-8. PubMed ID: 7966238
[TBL] [Abstract][Full Text] [Related]
39. Increased stability and limited proliferation of CD4+ central memory T cells differentiate nonprogressive simian immunodeficiency virus (SIV) infection of sooty mangabeys from progressive SIV infection of rhesus macaques.
McGary CS; Cervasi B; Chahroudi A; Micci L; Taaffe J; Meeker T; Silvestri G; Davenport MP; Paiardini M
J Virol; 2014 Apr; 88(8):4533-42. PubMed ID: 24501416
[TBL] [Abstract][Full Text] [Related]
40. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
